MRVI1

From Wikipedia, the free encyclopedia


Murine retrovirus integration site 1 homolog
Identifiers
Symbol(s) MRVI1; IRAG; JAW1L
External IDs OMIM: 604673 MGI1338023 HomoloGene4425
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 10335 17540
Ensembl ENSG00000072952 ENSMUSG00000005611
Refseq NM_006069 (mRNA)
NP_006060 (protein)
NM_010826 (mRNA)
NP_034956 (protein)
Location Chr 11: 10.55 - 10.63 Mb Chr 7: 110.66 - 110.77 Mb
Pubmed search [1] [2]

Murine retrovirus integration site 1 homolog, also known as MRVI1, is a human gene.[1]

This gene is similar to a mouse putative tumor suppressor gene that is frequently disrupted by mouse AIDS-related virus (MRV). The encoded protein, which is found in the membrane of the endoplasmic reticulum, is similar to Jaw1, a lymphoid-restricted protein whose expression is downregulated during myeloid differentiation. Therefore, this gene may be a myeloid leukemia tumor suppressor gene. Several alternatively spliced transcripts have been found for this gene, however, the full-length nature of some variants has not been determined. Of the two characterized variants which encode different isoforms, one initiates translation at a non-AUG start site.[1]

[edit] References

[edit] Further reading

  • Adams MD, Dubnick M, Kerlavage AR, et al. (1992). "Sequence identification of 2,375 human brain genes.". Nature 355 (6361): 632–4. doi:10.1038/355632a0. PMID 1538749. 
  • Baltensperger K, Chiesi M, Carafoli E (1991). "Substrates of cGMP kinase in vascular smooth muscle and their role in the relaxation process.". Biochemistry 29 (41): 9753–60. PMID 2271613. 
  • Shaughnessy JD, Largaespada DA, Tian E, et al. (1999). "Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1.". Oncogene 18 (12): 2069–84. doi:10.1038/sj.onc.1202419. PMID 10321731. 
  • Schlossmann J, Ammendola A, Ashman K, et al. (2000). "Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta.". Nature 404 (6774): 197–201. doi:10.1038/35004606. PMID 10724174. 
  • Ammendola A, Geiselhöringer A, Hofmann F, Schlossmann J (2001). "Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta.". J. Biol. Chem. 276 (26): 24153–9. doi:10.1074/jbc.M101530200. PMID 11309393. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Koller A, Schlossmann J, Ashman K, et al. (2003). "Association of phospholamban with a cGMP kinase signaling complex.". Biochem. Biophys. Res. Commun. 300 (1): 155–60. PMID 12480535. 
  • Fritsch RM, Saur D, Kurjak M, et al. (2004). "InsP3R-associated cGMP kinase substrate (IRAG) is essential for nitric oxide-induced inhibition of calcium signaling in human colonic smooth muscle.". J. Biol. Chem. 279 (13): 12551–9. doi:10.1074/jbc.M313365200. PMID 14729908. 
  • Casteel DE, Boss GR, Pilz RB (2006). "Identification of the interface between cGMP-dependent protein kinase Ibeta and its interaction partners TFII-I and IRAG reveals a common interaction motif.". J. Biol. Chem. 280 (46): 38211–8. doi:10.1074/jbc.M507021200. PMID 16166082. 
  • Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMID 16344560. 
  • Antl M, von Brühl ML, Eiglsperger C, et al. (2007). "IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation.". Blood 109 (2): 552–9. doi:10.1182/blood-2005-10-026294. PMID 16990611.